Biocon Limited — ≥1% Shareholders
Every non-promoter shareholder owning 1% or more of Biocon Limited, parsed from the latest quarterly Shareholding Pattern filing. Curated holders link to a tracked profile; mystery holders are flagged.
0 curated
11 mystery
Quarter: Mar 2026
Institutional intelligence for Biocon Limited
Cross-view mutual fund activity and super-investor shareholding · Mar 2026 SHP.
| Holder | Type | % of company | Shares | Value (₹ Cr) |
|---|---|---|---|---|
| KIRAN MAZUMDAR SHAW | individual | 29.90% | 48,45,81,970 | — |
| GLENTEC INTERNATIONAL | fii | 14.63% | 23,72,11,164 | — |
| SBI LARGE & MIDCAP FUND | dii | 8.20% | 13,29,91,385 | — |
| MYLAN INC. | fii | 5.67% | 9,19,67,019 | — |
| LICI NEW PENSION PLUS GROWTH FUND | dii | 3.87% | 6,27,93,704 | — |
| SERUM INSTITUTE LIFE SCIENCES PRIVATE LIMITED | dii | 3.42% | 5,54,48,765 | — |
| ICICI PRUDENTIAL INNOVATION FUND | dii | 2.40% | 3,88,50,342 | — |
| MIRAE ASSET NIFTY MIDCAP 150 ETF | dii | 1.25% | 2,02,05,321 | — |
| NIPPON LIFE INDIA TRUSTEE LTD- A/C NIPPON INDIA VI | dii | 1.12% | 1,81,65,211 | — |
| ACTIV PINE LLP | dii | 1.09% | 1,76,58,180 | — |
| KOTAK LARGE & MIDCAP FUND | dii | 1.02% | 1,66,10,890 | — |
Shareholding data sourced from NSE/BSE regulatory filings. Not investment advice. See our disclaimer and methodology.